Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -43.69% is 52% below its 5-year average of -28.82%, around the middle of its 5-year range (-61.82%–-8.48%).
As of the fiscal period ended Tuesday, June 30, 2026. 87.38% below its 12-month average of -23.31%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -43.69%.
RETURN ON INVESTED CAPITAL (ROIC)
-43.69%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-23.31%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-32.30%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-28.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-87.38%
CURRENT VS 3Y AVG
-35.25%
CURRENT VS 5Y AVG
-51.59%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-31.62%
median of 545 covered companies
CURRENT VS SECTOR MEDIAN
-38.17%
vs the sector median at left
Century Therapeutics, Inc.
Market Cap
$260.75M
Return on Invested Capital (ROIC)
-43.69%
TTM Avg
-23.31%
3Y Avg
-32.30%
5Y Avg
-28.82%
Market Cap
$262.00M
Return on Invested Capital (ROIC)
-170.19%
TTM Avg
-56.97%
3Y Avg
-50.85%
5Y Avg
-45.83%
Market Cap
$258.73M
Return on Invested Capital (ROIC)
-39.76%
TTM Avg
-63.41%
3Y Avg
-63.96%
5Y Avg
-51.83%
Market Cap
$260.09M
Return on Invested Capital (ROIC)
-3.17%
TTM Avg
-4.70%
3Y Avg
-2.14%
5Y Avg
-2.73%
Market Cap
$264.73M
Return on Invested Capital (ROIC)
-42.92%
TTM Avg
-30.10%
3Y Avg
-80.25%
5Y Avg
-64.52%
Market Cap
$265.63M
Return on Invested Capital (ROIC)
-89.43%
TTM Avg
-77.88%
3Y Avg
-57.02%
5Y Avg
-48.01%
Market Cap
$266.50M
Return on Invested Capital (ROIC)
-43.56%
TTM Avg
-66.27%
3Y Avg
-114.94%
5Y Avg
-104.61%
Market Cap
$275.02M
Return on Invested Capital (ROIC)
-15.69%
TTM Avg
-4.06%
3Y Avg
-9.73%
5Y Avg
-12.88%
Market Cap
$251.33M
Return on Invested Capital (ROIC)
-59.90%
TTM Avg
-142.39%
3Y Avg
-118.24%
5Y Avg
-103.50%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Century Therapeutics, Inc. (IPSC) | $260.75M | -43.69% | -23.31% | -32.30% | -28.82% |
| EyePoint Pharmaceuticals, Inc. (EYPT)vs › | $262.00M | -170.19% | -56.97% | -50.85% | -45.83% |
| Lexeo Therapeutics, Inc. Common Stock (LXEO)vs › | $258.73M | -39.76% | -63.41% | -63.96% | -51.83% |
| Anika Therapeutics, Inc. (ANIK)vs › | $260.09M | -3.17% | -4.70% | -2.14% | -2.73% |
| Inhibikase Therapeutics, Inc. (IKT)vs › | $264.73M | -42.92% | -30.10% | -80.25% | -64.52% |
| AC Immune S.A. (ACIU)vs › | $265.63M | -89.43% | -77.88% | -57.02% | -48.01% |
| Eupraxia Pharmaceuticals Inc. (EPRX)vs › | $266.50M | -43.56% | -66.27% | -114.94% | -104.61% |
| Aurora Cannabis Inc. (ACB)vs › | $275.02M | -15.69% | -4.06% | -9.73% | -12.88% |
| Invivyd, Inc. (IVVD)vs › | $251.33M | -59.90% | -142.39% | -118.24% | -103.50% |
| Greenwich LifeSciences, Inc. (GLSI)vs › | $243.66M | -701.55% | -3723.51% | -1911.77% | -1278.48% |
ROIC
-43.7%
ROE
-47.3%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -43.69% |
| 2026-03-31 | -37.36% |
| 2025-12-31 | -8.48% |
| 2025-09-30 | -14.97% |
| 2025-06-30 | -12.07% |
| 2025-03-31 | -10.67% |
| 2024-12-31 | -61.82% |
| 2024-09-30 | -38.82% |
| 2024-06-30 | -36.61% |
| 2024-03-31 | -43.85% |
| 2023-12-31 | -42.56% |
| 2023-09-30 | -35.89% |
| 2023-06-30 | -33.12% |
| 2023-03-31 | -29.24% |
| 2022-12-31 | -28.89% |
| 2022-09-30 | -26.28% |
| 2022-06-30 | -23.91% |
| 2022-03-31 | -21.63% |
| 2021-12-31 | -22.44% |
| 2021-09-30 | -18.27% |
| 2021-06-30 | -14.64% |
| 2021-03-31 | -20.96% |
| 2020-12-31 | -51.95% |
